Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
16.83
+0.23 (1.39%)
At close: Aug 21, 2026, 4:00 PM EDT
16.80
-0.03 (-0.20%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Rallybio Market Cap
Rallybio has a market cap or net worth of $89.38 million as of August 21, 2026. Its market cap has increased by 252.77% in one year.
Market Cap
89.38M
Enterprise Value
-3.47M
1-Year Change
252.77%
Ranking
Category
Stock Price
$16.83
ChartMarket Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $89.38M, a decrease of -77.96%. That is a compound annual growth rate of -25.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 89.38M | 208.37% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 97.37M |
| Fortress Biotech | 95.72M |
| Acrivon Therapeutics | 94.71M |
| Cognition Therapeutics | 94.70M |
| Aldeyra Therapeutics | 91.70M |
| ImmuCell | 91.37M |
| Gain Therapeutics | 87.51M |
| Eloxx Pharmaceuticals | 84.66M |